Case Report: Circulating Anti-SARS-CoV-2 Antibodies Do Not Cross-React With Pemphigus or Pemphigoid Autoantigens

Letter Dermatology

Association between vaccination and autoimmune bullous diseases: A systematic review

Michael Kasperkiewicz et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2022)

添加到收藏夹

Letter Dermatology

COVID-19 outbreak and autoimmune bullous diseases: A systematic review of published cases

Michael Kasperkiewicz

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)

添加到收藏夹

Letter Cell Biology

Covid-19, heat shock proteins, and autoimmune bullous diseases: a potential link deserving further attention

Michael Kasperkiewicz

Summary: A potential link between Covid-19 and the development of autoimmune diseases has been suggested, possibly due to molecular similarities between SARS-CoV-2 and human proteins. Research has shown shared peptides between antigenic epitopes of the virus and heat shock proteins, indicating a possible autoimmune response.

CELL STRESS & CHAPERONES (2021)

添加到收藏夹

Article Immunology

Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications for Autoimmune Diseases

Aristo Vojdani et al.

Summary: The study found immune reactivity between SARS-CoV-2 antibodies and various human tissue antigens, as well as similarities between COVID-19 viral proteins and human tissue antigens. This extensive immune cross-reactivity may impact the disease progression of COVID-19, affecting disease severity, triggering autoimmunity, and exacerbating pre-existing autoimmune diseases. The results highlight potential risks for autoimmunity and multi-system disorders with COVID-19, emphasizing the importance of ensuring the safety of vaccines and treatments against this disease.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Letter Dermatology

Updated international expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemic

M. Kasperkiewicz et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)

添加到收藏夹

Article Cell Biology

Autoantibodies to heat shock protein 60, 70, and 90 are not altered in the anti-SARS-CoV-2 IgG-seropositive humans without or with mild symptoms

Jagoda Mantej et al.

Summary: The study did not find evidence of autoimmunity against extracellular heat shock proteins caused by SARS-CoV-2, but further testing for cell-based immunity is needed for a complete evaluation of this hypothesis.

CELL STRESS & CHAPERONES (2021)

添加到收藏夹

Editorial Material Allergy

Subepidermal blistering eruptions, including bullous pemphigoid, following COVID-19 vaccination

Mary M. Tomayko et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

添加到收藏夹

Case Report: Circulating Anti-SARS-CoV-2 Antibodies Do Not Cross-React With Pemphigus or Pemphigoid Autoantigens

相关参考文献

Association between vaccination and autoimmune bullous diseases: A systematic review

COVID-19 outbreak and autoimmune bullous diseases: A systematic review of published cases

Covid-19, heat shock proteins, and autoimmune bullous diseases: a potential link deserving further attention

Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications for Autoimmune Diseases

Updated international expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemic

Autoantibodies to heat shock protein 60, 70, and 90 are not altered in the anti-SARS-CoV-2 IgG-seropositive humans without or with mild symptoms

Subepidermal blistering eruptions, including bullous pemphigoid, following COVID-19 vaccination

导出引文

分享论文